rAAV see Recombinant adenoassociated virus Radioenzymatic assay, 344 Ran-2 antibody, 29 Rearrangements of cytoskeleton, 11S Recombinant adenoassociated viral construct, S4

Recombinant adenoassociated virus, S4 Redistribution of axolemmal ion-channels, 211 Reduced medial temporal lobe NAA in ClND, 250

Reduced NAA in ALS, 260 Reduction of hippocampal NAA in PTSD, 251 Regulation of NAA synthesis in brain, 267-274 Regulation of NAAG expression activity dependent, 300 Relationship of CMRglc to neurons, 253 Re-myelination process, 40 Replication-incompetent recombinant version, S4

Respiratory chain inhibitor, 59

Retinal ganglion cells, 293

Retinal-tectal pathway, 3

Reversible NAA losses of, 251

Riluzole as disease modifying agent, 2S0 see also Disease modifying agent riluzole Role of NAA in MS, 204 Role of NAAG in pathologies of CNS, 321 Rostro-caudal gradient, 344

Was this article helpful?

0 0

Post a comment